Lyrica
- Product NDC
- 35356-054
- 11-digit product format
- 353560054
- Labeler code
- 35356
- Product ID
- 35356-054_97944e21-ffe2-4e43-87ed-2031b7431423
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PREGABALIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Quality Care Products, LLC
- Application
- NDA021446
- Marketing category
- NDA
- Marketing start
- 2004-12-30
- Marketing end
- 0000-00-00
- Substance
- PREGABALIN
- Active strength
- 150 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 35356-054-30 | 2022-11-08 | C162847 | 48780-1 | ba0f9c33-4f2e-a910-e053-dadaa90a0b85 | ba5d931f-5341-44cf-979c-a3df4f3cae3a |
| 35356-054-60 | 2022-11-08 | C162847 | 48780-1 | ba0f9c33-4f2e-a910-e053-dadaa90a0b85 | ba5d931f-5341-44cf-979c-a3df4f3cae3a |
| 35356-054-90 | 2022-11-08 | C162847 | 48780-1 | ba0f9c33-4f2e-a910-e053-dadaa90a0b85 | ba5d931f-5341-44cf-979c-a3df4f3cae3a |
| 35356-054-30 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4f2e-a910-e053-dadaa90a0b85 | ba5d931f-5341-44cf-979c-a3df4f3cae3a |
| 35356-054-60 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4f2e-a910-e053-dadaa90a0b85 | ba5d931f-5341-44cf-979c-a3df4f3cae3a |
| 35356-054-90 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4f2e-a910-e053-dadaa90a0b85 | ba5d931f-5341-44cf-979c-a3df4f3cae3a |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 35356-054-30 | EA - Each | 35356-054 | 9a0225bf-1b88-4e11-9cf4-8b875b156220 | 1 | 2012-07-24 |
| 35356-054-60 | EA - Each | 35356-054 | 5da66617-bbcc-4697-9f4d-0f512f512bf7 | 1 | 2012-07-24 |
| 35356-054-90 | EA - Each | 35356-054 | 9a3685d8-1702-431b-a2c7-8cf5293a79af | 1 | 2012-07-24 |